A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials

25Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

Current HIV vaccines are only partially efficacious, presenting an opportunity to identify correlates of protection and, thereby, potential insight into mechanisms that prevent HIV acquisition. Two independent preclinical challenge studies in nonhuman primates (NHPs) previously showed partial efficacy of a mosaic adenovirus 26 (Ad26)-based HIV-1 vaccine candidate. To investigate the basis of this protection, we performed whole transcriptomics profiling by RNA sequencing (RNA-seq) in sorted lymphocytes from peripheral blood samples taken during these studies at different time points after vaccination but before challenge. We observed a transcriptional signature in B cells that associated with protection from acquisition of simian immunodeficiency virus (SIV) or the simian-human immunodeficiency virus (SHIV) in both studies. Strong antibody responses were elicited, and genes from the signature for which expression was enriched specifically associated with higher magnitude of functional antibody responses. The same gene expression signature also associated with protection in RV144 in the only human HIV vaccine trial to date that has shown efficacy and in two additional NHP studies that evaluated similar canarypox-based vaccine regimens. A composite gene expression score derived from the gene signature was one of the top-ranked correlates of protection in the NHP vaccine studies. This study aims to bridge preclinical and clinical data with the identification of a gene signature in B cells that is associated with protection from SIV and HIV infection by providing a new approach for evaluating future vaccine candidates.

References Powered by Scopus

Trimmomatic: A flexible trimmer for Illumina sequence data

42273Citations
N/AReaders
Get full text

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

36149Citations
N/AReaders
Get full text

Regression Shrinkage and Selection Via the Lasso

35799Citations
N/AReaders
Get full text

Cited by Powered by Scopus

mRNA-1273 and BNT162b2 COVID-19 vaccines elicit antibodies with differences in Fc-mediated effector functions

90Citations
N/AReaders
Get full text

Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge

40Citations
N/AReaders
Get full text

Passive Transfer of Vaccine-Elicited Antibodies Protects against SIV in Rhesus Macaques

26Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ehrenberg, P. K., Shangguan, S., Issac, B., Alter, G., Geretz, A., Izumi, T., … Thomas, R. (2019). A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials. Science Translational Medicine, 11(507). https://doi.org/10.1126/scitranslmed.aaw4236

Readers over time

‘19‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 20

54%

Researcher 10

27%

Professor / Associate Prof. 7

19%

Readers' Discipline

Tooltip

Immunology and Microbiology 18

49%

Biochemistry, Genetics and Molecular Bi... 9

24%

Medicine and Dentistry 6

16%

Agricultural and Biological Sciences 4

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 2
News Mentions: 1
Social Media
Shares, Likes & Comments: 50

Save time finding and organizing research with Mendeley

Sign up for free
0